ISOQ inhibited both platelet aggregation and Factor Xa generation induced by tumor cells and significantly suppressed tumor growth, thromboinflammatory markers, and expression of tissue factor, VEGF, TMEM176B, and PD‐L1. Here, CD274 is linked to neoplasm.